Home Markets U.S. Medicare plans to cover Biogen Alzheimer’s drug only for trial patients

U.S. Medicare plans to cover Biogen Alzheimer’s drug only for trial patients

Jan 12, 2022 comments off

Original source: https://www.investing.com/news/stock-market-news/future-of-biogens-aduhelm-hinges-on-us-medicare-alzheimers-coverage-2735646

You May Also Like

Walmart, Target outpace peers in AI-driven supply chain race, Jefferies says

Booking, Expedia face margin pressure from AI agents, Bernstein says

Goldman: Software giants face ‘radical transformation’ as agentic AI rises

Musk says Tesla’s mega AI chip fab project to launch in seven days

Fertitta Entertainment in talks to buy Caesars for $6.5 billion, CNBC reports

Wall Street posts three-week losing streak as Iran war batters sentiment